EKSO BIONICS HOLDINGS, INC. 4
4 · EKSO BIONICS HOLDINGS, INC. · Filed Nov 15, 2016
Insider Transaction Report
Form 4
SCHEDER-BIESCHIN MAX
Chief Financial Officer
Transactions
- Purchase
Common Stock
2016-11-11$4.00/sh+1,000$3,995→ 9,817 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.986 to $3.996. The Reporting Person undertakes to provide Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.